CVS HEALTH CORPORATION
CVSCVS Health Corporation is a healthcare company that operates the largest pharmacy chain in the United States, offering prescription drugs, health and wellness products, and retail clinics. Founded in 1963, it has expanded to include health insurance services through its acquisition of Aetna, aiming to integrate pharmacy, health, and wellness services for consumers.
Dividend History
Investors can expect a dividend payout of $0.67 per share, scheduled to be distributed in 16 days on August 3, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 3, 2026 | $0.67 | 2026-07-23 | 2026-07-23 |
| May 4, 2026 | $0.67 | 2026-04-23 | 2026-04-23 |
| February 2, 2026 | $0.67 | 2026-01-22 | 2026-01-22 |
| November 3, 2025 | $0.67 | 2025-10-23 | 2025-10-23 |
| August 1, 2025 | $0.67 | 2025-07-22 | 2025-07-22 |
Dividends Summary
- Consistent Payer: CVS HEALTH CORPORATION has rewarded shareholders with 91 dividend payments over the past 22 years.
- Total Returned Value: Investors who held CVS shares during this period received a total of $29.96 per share in dividend income.
- Latest Payout: The most recent dividend of $0.67/share was paid 75 days ago, on May 4, 2026.
- Yield & Schedule: CVS currently pays dividends quarterly with an annual yield of 2.48%.
- Dividend Growth: Since 2004, the dividend payout has grown by 903.8%, from $0.07 to $0.67.
- Dividend Reliability: CVS has maintained or increased its dividend for 85 consecutive payments.
Company News
Two closed-end funds (CEFs) are trading at significant discounts to net asset value due to market concerns about interest rates under new Fed Chair Kevin Warsh's inflation-focused approach. BlackRock Enhanced Equity Dividend Trust (BDJ) offers a 7.8% monthly dividend at a 6.7% discount, while BlackRock Multi-Sector Income Trust (BIT) provides an ...
The global healthcare services market is projected to grow from USD 8.62 trillion in 2025 to USD 20.10 trillion by 2035, with a CAGR of 8.87%. Growth is driven by rising chronic disease prevalence, aging populations, and digital healthcare adoption including telehealth and AI-enabled care. The U.S. market is expected to reach USD 4.93 trillion an...
Fluency has issued a retraction notice advising that a previous news release from June 11, 2026, regarding CVS using Fluency to close enterprise AI deployment gaps should be disregarded by journalists and readers.
Autonomize, a healthcare AI company, announced the appointment of three distinguished leaders to its Advisory Board—Dr. Brian Anderson (CEO of Coalition for Health AI), Bill Fandrich (healthcare and financial services executive), and Keith Reynolds (COO of Welldoc)—along with Mike Longacre as Head of Transformation. These appointments aim to ...
Mizuho analyst Ann Hynes raised her CVS Health price target to $115 per share, implying 13% upside from current levels. The article suggests CVS could see even greater upside potential, potentially reaching $150 per share if it achieves a valuation multiple similar to UnitedHealth Group, given its transformation into a diversified healthcare serv...
